In COVID-19 patients, the other proposed therapeutic mechanism of factor Xa inhibitor on CoV cellular infection is that SARS coronavirus binds to the host cell expressing a receptor of the coronavirus spike protein. This evidence concerns the gene F10 and COVID-19.